Animal testing is yesterday's gold standard. AxoSim's NerveSim™, powered by Nerve-on-a-Chip®, delivers human data, faster to save you hundreds of millions of dollars and years of wasted patent life, while allowing you to develop more effective drugs.
Learn More
Our technology enables researchers to predict human outcomes in the lab. We deliver accurate preclinical testing to help develop safer, more effective drugs.
Almost 90% of drugs that look promising in animal models fail when tested in humans, driving up the average cost and time of new drug development to $2.6 billion and 10 years or more. We deliver predictive human data in just weeks and at a fraction of the cost of in vivo studies.
Achieve the predictive readouts critical to your R&D success. We deliver clinically-relevant functional and structural metrics to improve success rates.
AxoSim's NerveSim™ Platform, powered by Nerve-on-a-Chip® facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.
BrainSim™ is a high quality 3D miniature brain organoid designed to serve as a human-relevant model in preclinical drug discovery.
May 11, 2020 Recent publication in ALTEX demonstrates prediction of clinical peripheral neuropathy by chemotherapeutic drugs using NerveSim™ powered by Nerve-on-a-Chip® Using […]
Read MoreAxoSim Chief Science Officer and Co-Founder, Dr. Michael J. Moore, presented Nerve-on-a-Chip pain model at the NIH Tissue Chips Consortium Meeting March […]
Read MoreRecent study shows AxoSim’s ability to recapitulate results for a client in drug-induced peripheral neuropathy AxoSim was hired by one of the […]
Read MoreNow, more than ever, it’s critical we continue advancing drug development. AxoSim is here to help. Our world has entered a new […]
Read More
